Meloxicam-Paracetamol Binary Solid Dispersion Systems with Enhanced Solubility and Dissolution Rate:Preparation, Characterization, and In Vivo Evaluation-Reference-Cited by-同舟云学术

Meloxicam-Paracetamol Binary Solid Dispersion Systems with Enhanced Solubility and Dissolution Rate:Preparation, Characterization, and In Vivo Evaluation

Published:2017-04-10 Issue:3 Volume:12 Page:206-215
ISSN:1872-5120
Container-title:Journal of Pharmaceutical Innovation
language:en
Short-container-title:J Pharm Innov

Author:

Al-Remawi Mayyas,Ali Ahmed Mahmoud Abdelhaleem,Khames Ahmed,Hamaidi Mohammad

Funder

Taif University

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmaceutical Science

Link

http://link.springer.com/article/10.1007/s12247-017-9281-1/fulltext.html

Reference40 articles.

1. Hawkey C, Kahan A, Steinbruck K, Alegre C, Baumelou E, Begaud B, Dequeker J, Isomaki H, Littlejohn G, Mau J. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment. Rheumatology. 1998;37:937–45.

2. Eroglu H, Burul-Bozkurt N, Uma S, Oner L. Preparation and in vitro/in vivo evaluation of microparticle formulations containing meloxicam. AAPS PharmSciTech. 13:46–52.

3. Hughey JR, Keen JM, Brough C, Saeger S, McGinity JW. Thermal processing of a poorly water-soluble drug substance exhibiting a high melting point: the utility of KinetiSol® Dispersing. Int J Pharm. 2011;419:222–30.

4. El-Badry M, Fathy M. Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinylpyrrolidone K-30. Drug Dev Ind Pharm. 2006;32:141–50.

5. Vijaya Kumar SG, Mishra DN. Preparation, characterization and in vitro dissolution studies of solid dispersion of meloxicam with PEG 60001. Yakugaku Zasshi. 2006;126:657–64.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modification of the Physicochemical Properties of Active Pharmaceutical Ingredients via Lyophilization;Pharmaceutics;2023-11-09

2. Co-Amorphous System (Paracetamol:Indomethacin): Investigations on Physical Stability and Intermolecular Interactions;Pharmaceutical Chemistry Journal;2023-11

3. Assessment of dissolution, disintegration time, and acid-neutralizing capacity of Butaproxyvon capsules (Paracetamol 325mg and diclofenac potassium 50mg);Indian Journal of Pharmacy and Pharmacology;2023-10-15

4. Current Trends on Solid Dispersions: Past, Present, and Future;Advances in Pharmacological and Pharmaceutical Sciences;2022-10-22

5. Preparation and Evaluation of Co-amorphous Formulations of Telmisartan—Amino Acids as a Potential Method for Solubility and Dissolution Enhancement;AAPS PharmSciTech;2021-03-21